- Home
- CRBP vs TPIC Comparison
CRBP vs TPIC Comparison
Compare CRBP & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- TPIC
- Stock Information
- Founded
- CRBP 2009
- TPIC 1968
- Country
- CRBP United States
- TPIC United States
- Employees
- CRBP N/A
- TPIC N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- TPIC Industrial Machinery/Components
- Sector
- CRBP Health Care
- TPIC Industrials
- Exchange
- CRBP Nasdaq
- TPIC Nasdaq
- Market Cap
- CRBP 73.4M
- TPIC 65.6M
- IPO Year
- CRBP N/A
- TPIC 2016
- Fundamental
- Price
- CRBP $6.03
- TPIC $0.73
- Analyst Decision
- CRBP Strong Buy
- TPIC Hold
- Analyst Count
- CRBP 10
- TPIC 6
- Target Price
- CRBP $60.89
- TPIC $1.86
- AVG Volume (30 Days)
- CRBP 207.2K
- TPIC 684.9K
- Earning Date
- CRBP 05-06-2025
- TPIC 05-08-2025
- Dividend Yield
- CRBP N/A
- TPIC N/A
- EPS Growth
- CRBP N/A
- TPIC N/A
- EPS
- CRBP N/A
- TPIC N/A
- Revenue
- CRBP N/A
- TPIC $1,331,131,000.00
- Revenue This Year
- CRBP N/A
- TPIC $8.93
- Revenue Next Year
- CRBP $150.00
- TPIC $9.59
- P/E Ratio
- CRBP N/A
- TPIC N/A
- Revenue Growth
- CRBP N/A
- TPIC N/A
- 52 Week Low
- CRBP $4.64
- TPIC $0.64
- 52 Week High
- CRBP $61.90
- TPIC $5.75
- Technical
- Relative Strength Index (RSI)
- CRBP 49.07
- TPIC 40.56
- Support Level
- CRBP $5.68
- TPIC $0.73
- Resistance Level
- CRBP $6.29
- TPIC $0.92
- Average True Range (ATR)
- CRBP 0.46
- TPIC 0.09
- MACD
- CRBP 0.19
- TPIC 0.01
- Stochastic Oscillator
- CRBP 84.24
- TPIC 31.10
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.